ResearcherNanjing Medical UniversityActive in the last 2 years

Xiao Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4373-6117; OpenAlex author ID A5081671999. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Transcription factor DDIT3 is a potential driver in pancreatic cancer. Last author DOI 10.14715/cmb/2024.70.7.21 ↗
Transcription factor p8 regulates autophagy in response to disulfiram via PI3K/mTOR/p70S6K signaling pathway in pancreatic cancer cells. Last author DOI 10.1007/s13577-022-00731-3 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fangzhou Liu · 2 shared papers, 2022–2024 · strength 0.40
- Paper Transcription factor DDIT3 is a potential driver in pancreatic cancer. DOI 10.14715/cmb/2024.70.7.21 ↗
- Paper Transcription factor p8 regulates autophagy in response to disulfiram via PI3K/mTOR/p70S6K signaling pathway in pancrea… DOI 10.1007/s13577-022-00731-3 ↗
Guoyuan Ju · 1 shared paper, 2024 · strength 0.24
- Paper Transcription factor DDIT3 is a potential driver in pancreatic cancer. DOI 10.14715/cmb/2024.70.7.21 ↗
Zhangyu Yao · 1 shared paper, 2022 · strength 0.16
- Paper Transcription factor p8 regulates autophagy in response to disulfiram via PI3K/mTOR/p70S6K signaling pathway in pancrea… DOI 10.1007/s13577-022-00731-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.